L. Marques

发表

The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis

Paige L. Williams, M. Yotebieng, C. Giaquinto, 2018, PLoS medicine.

Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study

C. Königs, C. Giaquinto, D. Pajkrt, 2018, PLoS medicine.

Outcomes of second‐line antiretroviral therapy among children living with HIV: a global cohort analysis

M. Yotebieng, C. Giaquinto, L. Mofenson, 2020, Journal of the International AIDS Society.

Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV‐1 infection 2015: optimizing health in preparation for adult life

C. Giaquinto, N. Klein, D. Gibb, 2015, HIV medicine.

Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand

C. Königs, C. Giaquinto, T. Puthanakit, 2022, Antiviral therapy.

Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature.

R. Lahesmaa, S. Jalkanen, R. Holmdahl, 2014, Antioxidants & redox signaling.

Variable Immunodeficiency Study. (Evaluation of two European cohorts within a variety of clinical phenotypes).

M. Fernández-arquero, S. Sánchez-Ramón, J. Vasconcelos, 2020, Immunology letters.

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

J. Seeley, C. Giaquinto, O. Kobusingye, 2021, BMC Infectious Diseases.

Acinetobacter community-acquired pneumonia in a healthy child.

L. Marques, L. Morais, V. Senra, 2012, Revista portuguesa de pneumologia.

A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD).

M. Fleming, P. Chakraborty, R. Klaassen, 2013, Blood.

Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD).

Erin K. Kennedy, M. Fleming, Ashley Lau, 2014, Blood.

HIV Infection Complications during Childhood

L. Marques, H. Machado, D. Pereira, 2017 .

Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV

D. Shingadia, E. Chiappini, E. Nastouli, 2016, HIV medicine.

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Ana C. Matos, C. Königs, C. Giaquinto, 2022, The lancet. HIV.

Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance

J. Casanova, L. F. Jobim, C. Deswarte, 2021, Journal of Clinical Immunology.

Neonatal screening for Severe Combined Immunodeficiency.

L. Marques, G. Matos, 2018 .

immunodeficiency, periodic fevers, and developmental delay (SIFD) A novel syndrome of congenital sideroblastic anemia, B-cell

M. Fleming, P. Chakraborty, R. Klaassen, 2013 .

[X-linked agammaglobulinemia: experience in a Portuguese hospital].

J. Vasconcelos, M. Guedes, L. Marques, 2015, Anales de pediatria.

Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand

C. Königs, C. Giaquinto, P. Palma, 2019, AIDS.

Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.

M. Yotebieng, C. Giaquinto, L. Mofenson, 2019, The lancet. HIV.

Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

A. Trkola, P. Tovey, C. Königs, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Ana C. Matos, C. Königs, J. Seeley, 2022, The lancet. HIV.

CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand

C. Königs, C. Giaquinto, D. Gibb, 2019, HIV medicine.

Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand

C. Giaquinto, A. Tostevin, L. Ene, 2016, European Journal of Clinical Pharmacology.

Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis

M. Yotebieng, C. Giaquinto, L. Mofenson, 2022, Journal of the International AIDS Society.

Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation.

P. Palma, T. Niehues, P. Rossi, 2016, Vaccine.

Children living with HIV in Europe: do migrants have worse treatment outcomes?

C. Giaquinto, L. Rodrigues, D. Gibb, 2021, HIV medicine.

Mother-to-child transmission of human immunodeficiency virus type 1 infection

L. Marques, A. Fernandes, A. Horta, 2016 .

Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)

Manuela Ferreira, M. Ramos, P. Paixão, 2019, Scientific Reports.

Long COVID in Children and Adolescents: A Retrospective Study in a Pediatric Cohort

L. Marques, A. Fernandes, C. Afonso, 2023, The Pediatric infectious disease journal.

Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit

P. van Damme, I. Barta, M. Bonten, 2022, JMIR public health and surveillance.

Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinic

J. Blackstone, E. Williams, C. Giaquinto, 2023, EClinicalMedicine.

Cutaneous leishmaniasis - two cases, two perspectives

M. Selores, L. Marques, S. Machado, 2019 .